Search
for
Sort by
Research 30 of 1000+
- 0248 Risk of infections in patients with hidradenitis suppurativa treated with TNF-α inhibitors vs. IL-17 inhibitors: A large-scale cohort study
- Platelet-rich plasma therapy: key infection prevention practices and strategies for safety risk reduction
- High-risk male teenager with concurrent gonorrhea and syphilis infection: An alarming call
- Alopecia areata and risk of common infections: a population-based cohort study
- Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review
- Cat Contact as A Risk Factor for Tinea Capitis Infection
- Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
- Opportunistic pathogenic fungal co-infections are prevalent in critically ill COVID-19 patients: Are they risk factors for disease severity?
- Complications Post-COVID-19 and Risk Factors among Patients after Six Months of a SARS-CoV-2 Infection: A Population-Based Prospective Cohort Study
- The Paediatric skin at risk: Challenges in burns, surgery and specific infections
- Hyaluronic Acid Hydrogel Incorporating Dexpanthenol-Engineered Extracellular Vesicles for Accelerated Wound Closure and Mitigated Secondary Infection Risk
- Clinical Characteristics, Quality of Life, and Risk Factors of Amputation Stump Skin Disease and Stump Fungal Infection in Adult Amputees in Shanghai, China
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart
- Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis
- Risk factors and comorbidities associated with central centrifugal cicatricial alopecia
- 69 Risk-benefit appraisal of systemic JAK inhibitors for alopecia areata: a comprehensive meta-analysis assessing safety and adverse effects
- Evaluation of Risk-Minimization Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 µg: A Cross-Sectional Physician Survey
- Cardiovascular disease risk in women with hyperandrogenism, oligomenorrhea/menstrual irregularity or polycystic ovaries (components of polycystic ovary syndrome): a systematic review and meta-analysis
- Medical and Environmental Risk Factors for the Development of Central Centrifugal Cicatricial Alopecia
- Benefit and risk profile of tofacitinib for the treatment of alopecia areata: a systemic review and meta‐analysis
- Acne keloidalis nuchae: risk factors and associated disorders – a retrospective study
- ASSESSMENT OF THE RISK OF DEVELOPING ALOPECIA IN PATIENTS AFTER CORONAVIRAL INFECTIONAND EFFECTIVE TREATMENT METHODS
- Polycystic Ovary Syndrome and the Metabolic Syndrome Long-Term Risks
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- Central hair loss in African American women: Incidence and potential risk factors
- Follicular Unit Extraction: Minimally Invasive Surgery for Hair Transplantation
- COVID-19 and hypopituitarism
- Immunosuppressive therapy in autoimmune disease — A review
- A Comprehensive Review on Platelet-Rich Plasma Activation: A Key Player in Accelerating Skin Wound Healing